WO2002036094A3 - Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells - Google Patents

Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells Download PDF

Info

Publication number
WO2002036094A3
WO2002036094A3 PCT/FR2001/003353 FR0103353W WO0236094A3 WO 2002036094 A3 WO2002036094 A3 WO 2002036094A3 FR 0103353 W FR0103353 W FR 0103353W WO 0236094 A3 WO0236094 A3 WO 0236094A3
Authority
WO
WIPO (PCT)
Prior art keywords
adhesion effect
dermatological
cells
cosmetic composition
circulating cells
Prior art date
Application number
PCT/FR2001/003353
Other languages
French (fr)
Other versions
WO2002036094A2 (en
Inventor
Francine Joly
Original Assignee
Sephra
Francine Joly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0013993A external-priority patent/FR2815872A1/en
Application filed by Sephra, Francine Joly filed Critical Sephra
Priority to EP01983642A priority Critical patent/EP1330235A2/en
Priority to AU2002215080A priority patent/AU2002215080A1/en
Publication of WO2002036094A2 publication Critical patent/WO2002036094A2/en
Publication of WO2002036094A3 publication Critical patent/WO2002036094A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the field of chemistry, and more particularly to the field of cosmetics and pharmaceutics, in particular dermatology. More particularly, it concerns a dermatological and/or cosmetic composition for implementing a method for treating sensitive skins and/or skins reactive to fumes, in particular tobacco smoke. The composition contains an active principle consisting of substances inhibiting adhesion effect, induced in particular by said fumes, of human circulating cells, in particular neutrocytes, lymphocytes, monocytes, acidophilic cells, to other cells or molecules of the extracellular matrix, in particular with human keratinocytes. Among the substances antagonists of said adhesion effect, the invention more particularly concerns compositions having as active principle a pyrrolidone-2 arginine carboxylate, in particular pyrrolidone-2 L-arginine carboxylate. The composition has soothing, anti-irritant, anti-inflammatory and anti-ageing effects on the skin.
PCT/FR2001/003353 2000-10-31 2001-10-26 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells WO2002036094A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01983642A EP1330235A2 (en) 2000-10-31 2001-10-26 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells
AU2002215080A AU2002215080A1 (en) 2000-10-31 2001-10-26 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR00/13993 2000-10-31
FR0013993A FR2815872A1 (en) 2000-10-31 2000-10-31 Topical use of arginine pyrrolidone-2-carboxylate as dermal pacifier, antiirritant, and antiaging agent
FR01/11643 2001-09-07
FR0111643A FR2815866B1 (en) 2000-10-31 2001-09-07 METHOD AND DERMATOLOGICAL AND / OR COSMETIC COMPOSITION ANTAGONIZING THE ADHESION EFFECT OF CIRCULATING CELLS

Publications (2)

Publication Number Publication Date
WO2002036094A2 WO2002036094A2 (en) 2002-05-10
WO2002036094A3 true WO2002036094A3 (en) 2002-08-08

Family

ID=26212709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/003353 WO2002036094A2 (en) 2000-10-31 2001-10-26 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells

Country Status (4)

Country Link
EP (1) EP1330235A2 (en)
AU (1) AU2002215080A1 (en)
FR (1) FR2815866B1 (en)
WO (1) WO2002036094A2 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
JPS5931706A (en) * 1982-08-17 1984-02-20 Lion Corp Cosmetic composition
JPS6130509A (en) * 1984-07-23 1986-02-12 Shiseido Co Ltd Dermal external drug
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
EP0511118A1 (en) * 1991-04-24 1992-10-28 L'oreal Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
WO1996028008A2 (en) * 1996-03-19 1996-09-19 Guerlain S.A. Novel cosmetic or dermatological compositions for controlling skin ageing
FR2778562A1 (en) * 1998-05-14 1999-11-19 Sephra Compositions containing sea water and basic amino acid inhibit mastocyte activation and basophile degranulation, useful as anti-allergics and anti-inflammatory agents for the skin, eyes, bronchi and nose
EP0979644A1 (en) * 1998-08-13 2000-02-16 Società Italo-Britannica L. Manetti-H. Roberts & C. S.p.A. Deodorant and/or moisturizing cosmetic composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
JPS5931706A (en) * 1982-08-17 1984-02-20 Lion Corp Cosmetic composition
JPS6130509A (en) * 1984-07-23 1986-02-12 Shiseido Co Ltd Dermal external drug
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
EP0511118A1 (en) * 1991-04-24 1992-10-28 L'oreal Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
WO1996028008A2 (en) * 1996-03-19 1996-09-19 Guerlain S.A. Novel cosmetic or dermatological compositions for controlling skin ageing
FR2778562A1 (en) * 1998-05-14 1999-11-19 Sephra Compositions containing sea water and basic amino acid inhibit mastocyte activation and basophile degranulation, useful as anti-allergics and anti-inflammatory agents for the skin, eyes, bronchi and nose
EP0979644A1 (en) * 1998-08-13 2000-02-16 Società Italo-Britannica L. Manetti-H. Roberts & C. S.p.A. Deodorant and/or moisturizing cosmetic composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 005, no. 136 (C - 069) 28 August 1981 (1981-08-28) *
PATENT ABSTRACTS OF JAPAN vol. 008, no. 118 (C - 226) 31 May 1984 (1984-05-31) *
PATENT ABSTRACTS OF JAPAN vol. 010, no. 182 (C - 356) 25 June 1986 (1986-06-25) *

Also Published As

Publication number Publication date
WO2002036094A2 (en) 2002-05-10
EP1330235A2 (en) 2003-07-30
FR2815866B1 (en) 2015-06-19
FR2815866A1 (en) 2002-05-03
AU2002215080A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
US8025907B2 (en) Cosmetic composition to accelerate repair of functional wrinkles
EP0738510A3 (en) Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.
WO2009068351A3 (en) Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k
WO1997013505A3 (en) USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE
WO2009090624A3 (en) Chitosan gel for dermatological use, production method therefor and use of same
EP2208509A3 (en) Topical compositions combining fragments of sodium hyaluronate and a retinoid
WO2008122516A3 (en) Sunscreen and personal care compositions comprising a select copolymer
ATE524486T1 (en) LYS-THR DIPEPTIDES AND THEIR USE
WO2008145692A3 (en) Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression
MX2009010484A (en) Sunscreen compositions comprising a random terpolymer.
MX9602973A (en) Use of bradyquinine antagonist in a cosmetic, pharmaceutical or dermatological composition, and composition obtained therefrom.
US20170042956A1 (en) Embelia concinna extract comprising flavonoids in cosmetic and pharmaceutical compositions
WO2000057836A3 (en) Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
EP1589984A4 (en) Topical composition and methods for treatment of aged or environmentally damaged skin
WO2004108064A3 (en) Diosgenin-based composition suitable for topical application
WO2002036094A3 (en) Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells
WO2010004099A3 (en) Skin-regenerating composition
WO2008050157A3 (en) Ozonated oil formulations
ATE228350T1 (en) USING A TERMINALIA CATAPPA EXTRACT
PL2100592T3 (en) Cosmetic product with anti-aging effect
WO2003070180A3 (en) Compositions and methods for delivery of skin cosmeceuticals
WO2005117897A3 (en) Hepoxilins and modulators of ichthyin for treatment skin disorders
WO2008009813A3 (en) Use of an extract of gleditsia in cosmetics and in dermatology
JP2020180072A (en) Anti-skin photoaging composition for external use
Mellody et al. The skin extracellular matrix as a target of environmental exposure: molecular mechanisms, prevention and repair

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001983642

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001983642

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001983642

Country of ref document: EP